nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—AOX1—Effects of Nitric Oxide—MB—sarcoma	0.0825	0.182	CbGpPWpGaD
Aminocaproic Acid—PLG—appendage—sarcoma	0.0443	0.155	CbGeAlD
Aminocaproic Acid—AOX1—Effects of Nitric Oxide—HBA1—sarcoma	0.0298	0.0657	CbGpPWpGaD
Aminocaproic Acid—PLG—endothelium—sarcoma	0.0268	0.0933	CbGeAlD
Aminocaproic Acid—PLG—Complement and Coagulation Cascades—CR2—sarcoma	0.0212	0.0468	CbGpPWpGaD
Aminocaproic Acid—PLAT—Complement and Coagulation Cascades—CR2—sarcoma	0.0212	0.0468	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—COL18A1—sarcoma	0.0193	0.0425	CbGpPWpGaD
Aminocaproic Acid—PLAT—mammary gland—sarcoma	0.0183	0.0639	CbGeAlD
Aminocaproic Acid—PLG—embryo—sarcoma	0.0147	0.0513	CbGeAlD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TEK—sarcoma	0.0139	0.0307	CbGpPWpGaD
Aminocaproic Acid—PLG—hematopoietic system—sarcoma	0.0131	0.0458	CbGeAlD
Aminocaproic Acid—PLAT—myometrium—sarcoma	0.013	0.0454	CbGeAlD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—sarcoma	0.0127	0.0281	CbGpPWpGaD
Aminocaproic Acid—PLG—connective tissue—sarcoma	0.0127	0.0441	CbGeAlD
Aminocaproic Acid—PLAT—seminal vesicle—sarcoma	0.0118	0.041	CbGeAlD
Aminocaproic Acid—PLG—smooth muscle tissue—sarcoma	0.0116	0.0403	CbGeAlD
Aminocaproic Acid—PLG—skin of body—sarcoma	0.0114	0.0398	CbGeAlD
Aminocaproic Acid—PLG—Syndecan-4-mediated signaling events—CXCR4—sarcoma	0.011	0.0243	CbGpPWpGaD
Aminocaproic Acid—PLG—uterus—sarcoma	0.00993	0.0346	CbGeAlD
Aminocaproic Acid—PLG—lymphoid tissue—sarcoma	0.00925	0.0322	CbGeAlD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—HBA1—sarcoma	0.00925	0.0204	CbGpPWpGaD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—HBA1—sarcoma	0.00925	0.0204	CbGpPWpGaD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—COL18A1—sarcoma	0.00849	0.0188	CbGpPWpGaD
Aminocaproic Acid—PLAT—cardiac atrium—sarcoma	0.00848	0.0296	CbGeAlD
Aminocaproic Acid—PLAT—uterus—sarcoma	0.00844	0.0294	CbGeAlD
Aminocaproic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP2—sarcoma	0.00769	0.017	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—HBA1—sarcoma	0.00753	0.0166	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—HBA1—sarcoma	0.00753	0.0166	CbGpPWpGaD
Aminocaproic Acid—PLAT—tendon—sarcoma	0.00739	0.0258	CbGeAlD
Aminocaproic Acid—PLG—testis—sarcoma	0.0072	0.0251	CbGeAlD
Aminocaproic Acid—AOX1—myometrium—sarcoma	0.00703	0.0245	CbGeAlD
Aminocaproic Acid—PLG—Platelet degranulation—VEGFC—sarcoma	0.00701	0.0155	CbGpPWpGaD
Aminocaproic Acid—PLG—liver—sarcoma	0.00681	0.0237	CbGeAlD
Aminocaproic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.00668	0.0147	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PDGFRB—sarcoma	0.00653	0.0144	CbGpPWpGaD
Aminocaproic Acid—Local reaction—Mitoxantrone—sarcoma	0.00643	0.0247	CcSEcCtD
Aminocaproic Acid—AOX1—seminal vesicle—sarcoma	0.00635	0.0221	CbGeAlD
Aminocaproic Acid—PLAT—NOTCH1 regulation of human endothelial cell calcification—VEGFA—sarcoma	0.00615	0.0136	CbGpPWpGaD
Aminocaproic Acid—PLAT—testis—sarcoma	0.00612	0.0213	CbGeAlD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—HBA1—sarcoma	0.00598	0.0132	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—HBA1—sarcoma	0.00598	0.0132	CbGpPWpGaD
Aminocaproic Acid—PLAT—liver—sarcoma	0.00579	0.0202	CbGeAlD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—FOXO1—sarcoma	0.00569	0.0126	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—MMP2—sarcoma	0.00549	0.0121	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—MMP2—sarcoma	0.00549	0.0121	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—MMP2—sarcoma	0.00549	0.0121	CbGpPWpGaD
Aminocaproic Acid—Coagulopathy—Dactinomycin—sarcoma	0.00526	0.0202	CcSEcCtD
Aminocaproic Acid—Necrosis—Dactinomycin—sarcoma	0.00522	0.0201	CcSEcCtD
Aminocaproic Acid—PLAT—Endochondral Ossification—IGF1R—sarcoma	0.00491	0.0108	CbGpPWpGaD
Aminocaproic Acid—Delirium—Thiotepa—sarcoma	0.0048	0.0184	CcSEcCtD
Aminocaproic Acid—AOX1—cardiac atrium—sarcoma	0.00458	0.016	CbGeAlD
Aminocaproic Acid—AOX1—uterus—sarcoma	0.00456	0.0159	CbGeAlD
Aminocaproic Acid—Necrosis—Mitoxantrone—sarcoma	0.00454	0.0175	CcSEcCtD
Aminocaproic Acid—PLAT—lymph node—sarcoma	0.00444	0.0155	CbGeAlD
Aminocaproic Acid—AOX1—tendon—sarcoma	0.004	0.0139	CbGeAlD
Aminocaproic Acid—Blood urea increased—Thiotepa—sarcoma	0.00389	0.015	CcSEcCtD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—sarcoma	0.00384	0.00849	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Etoposide—sarcoma	0.00378	0.0145	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—COL18A1—sarcoma	0.00356	0.00786	CbGpPWpGaD
Aminocaproic Acid—Myositis—Epirubicin—sarcoma	0.00339	0.013	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Mitoxantrone—sarcoma	0.00336	0.0129	CcSEcCtD
Aminocaproic Acid—AOX1—testis—sarcoma	0.00331	0.0115	CbGeAlD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IGF1R—sarcoma	0.0033	0.00729	CbGpPWpGaD
Aminocaproic Acid—Myositis—Doxorubicin—sarcoma	0.00313	0.012	CcSEcCtD
Aminocaproic Acid—AOX1—liver—sarcoma	0.00313	0.0109	CbGeAlD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.00311	0.00686	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—sarcoma	0.00306	0.00676	CbGpPWpGaD
Aminocaproic Acid—Local reaction—Epirubicin—sarcoma	0.003	0.0115	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—PLCG1—sarcoma	0.00285	0.0063	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PLCG1—sarcoma	0.00285	0.0063	CbGpPWpGaD
Aminocaproic Acid—Local reaction—Doxorubicin—sarcoma	0.00278	0.0107	CcSEcCtD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—sarcoma	0.00268	0.00593	CbGpPWpGaD
Aminocaproic Acid—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00267	0.0103	CcSEcCtD
Aminocaproic Acid—AOX1—Tryptophan metabolism—MDM2—sarcoma	0.00267	0.00589	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—IL2—sarcoma	0.00244	0.0054	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—IL2—sarcoma	0.00244	0.0054	CbGpPWpGaD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—MMP2—sarcoma	0.00242	0.00535	CbGpPWpGaD
Aminocaproic Acid—AOX1—lymph node—sarcoma	0.0024	0.00836	CbGeAlD
Aminocaproic Acid—Thrombosis—Epirubicin—sarcoma	0.00235	0.00902	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Vincristine—sarcoma	0.00234	0.009	CcSEcCtD
Aminocaproic Acid—Renal failure—Thiotepa—sarcoma	0.00227	0.00872	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Etoposide—sarcoma	0.00222	0.00855	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—TEK—sarcoma	0.00218	0.00482	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—TEK—sarcoma	0.00218	0.00482	CbGpPWpGaD
Aminocaproic Acid—Thrombosis—Doxorubicin—sarcoma	0.00217	0.00835	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Thiotepa—sarcoma	0.00215	0.00828	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Dactinomycin—sarcoma	0.00214	0.00822	CcSEcCtD
Aminocaproic Acid—PLAT—Endochondral Ossification—VEGFA—sarcoma	0.00213	0.0047	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Epirubicin—sarcoma	0.00212	0.00814	CcSEcCtD
Aminocaproic Acid—Hallucination—Thiotepa—sarcoma	0.00206	0.00793	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—FOXO1—sarcoma	0.00203	0.00447	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—FOXO1—sarcoma	0.00203	0.00447	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—PDGFRB—sarcoma	0.00202	0.00446	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PDGFRB—sarcoma	0.00202	0.00446	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—ANGPT2—sarcoma	0.002	0.00441	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—ANGPT2—sarcoma	0.002	0.00441	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PDGFRA—sarcoma	0.00199	0.00439	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—PDGFRA—sarcoma	0.00199	0.00439	CbGpPWpGaD
Aminocaproic Acid—Renal failure—Mitoxantrone—sarcoma	0.00196	0.00753	CcSEcCtD
Aminocaproic Acid—Necrosis—Doxorubicin—sarcoma	0.00196	0.00753	CcSEcCtD
Aminocaproic Acid—Tinnitus—Thiotepa—sarcoma	0.00193	0.00743	CcSEcCtD
Aminocaproic Acid—Delirium—Epirubicin—sarcoma	0.00193	0.00743	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—MDM2—sarcoma	0.00189	0.00417	CbGpPWpGaD
Aminocaproic Acid—Agranulocytosis—Mitoxantrone—sarcoma	0.00186	0.00715	CcSEcCtD
Aminocaproic Acid—Hallucination—Vincristine—sarcoma	0.00183	0.00703	CcSEcCtD
Aminocaproic Acid—Bradycardia—Mitoxantrone—sarcoma	0.00182	0.007	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Epirubicin—sarcoma	0.0018	0.00693	CcSEcCtD
Aminocaproic Acid—Delirium—Doxorubicin—sarcoma	0.00179	0.00687	CcSEcCtD
Aminocaproic Acid—PLG—Platelet degranulation—VEGFA—sarcoma	0.00178	0.00393	CbGpPWpGaD
Aminocaproic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.0017	0.00375	CbGpPWpGaD
Aminocaproic Acid—Lacrimation increased—Doxorubicin—sarcoma	0.00167	0.00641	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Epirubicin—sarcoma	0.00166	0.00639	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Dactinomycin—sarcoma	0.00166	0.00639	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Epirubicin—sarcoma	0.00165	0.00635	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—JUN—sarcoma	0.00164	0.00362	CbGpPWpGaD
Aminocaproic Acid—Renal failure—Etoposide—sarcoma	0.00163	0.00627	CcSEcCtD
Aminocaproic Acid—Leukopenia—Thiotepa—sarcoma	0.00161	0.00621	CcSEcCtD
Aminocaproic Acid—Malaise—Dactinomycin—sarcoma	0.00161	0.00621	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—VEGFC—sarcoma	0.0016	0.00354	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—VEGFC—sarcoma	0.0016	0.00354	CbGpPWpGaD
Aminocaproic Acid—Leukopenia—Dactinomycin—sarcoma	0.0016	0.00616	CcSEcCtD
Aminocaproic Acid—PLAT—Folate Metabolism—TP53—sarcoma	0.00157	0.00347	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—TP53—sarcoma	0.00157	0.00347	CbGpPWpGaD
Aminocaproic Acid—Blood urea increased—Epirubicin—sarcoma	0.00157	0.00603	CcSEcCtD
Aminocaproic Acid—Convulsion—Thiotepa—sarcoma	0.00156	0.00601	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Etoposide—sarcoma	0.00155	0.00595	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—KIT—sarcoma	0.00154	0.00341	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—KIT—sarcoma	0.00154	0.00341	CbGpPWpGaD
Aminocaproic Acid—Pulmonary embolism—Doxorubicin—sarcoma	0.00154	0.00591	CcSEcCtD
Aminocaproic Acid—Myalgia—Thiotepa—sarcoma	0.00154	0.0059	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Doxorubicin—sarcoma	0.00153	0.00587	CcSEcCtD
Aminocaproic Acid—Myalgia—Dactinomycin—sarcoma	0.00152	0.00586	CcSEcCtD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—TP53—sarcoma	0.00152	0.00334	CbGpPWpGaD
Aminocaproic Acid—Discomfort—Dactinomycin—sarcoma	0.00151	0.00579	CcSEcCtD
Aminocaproic Acid—Confusional state—Thiotepa—sarcoma	0.00148	0.00571	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—SRC—sarcoma	0.00147	0.00325	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—CREB1—sarcoma	0.00147	0.00324	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—CREB1—sarcoma	0.00147	0.00324	CbGpPWpGaD
Aminocaproic Acid—Oedema—Dactinomycin—sarcoma	0.00146	0.00562	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Doxorubicin—sarcoma	0.00145	0.00558	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Mitoxantrone—sarcoma	0.00144	0.00556	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Thiotepa—sarcoma	0.00144	0.00554	CcSEcCtD
Aminocaproic Acid—Leukopenia—Vincristine—sarcoma	0.00143	0.0055	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Dactinomycin—sarcoma	0.00143	0.0055	CcSEcCtD
Aminocaproic Acid—Malaise—Mitoxantrone—sarcoma	0.0014	0.0054	CcSEcCtD
Aminocaproic Acid—Leukopenia—Mitoxantrone—sarcoma	0.00139	0.00536	CcSEcCtD
Aminocaproic Acid—Convulsion—Vincristine—sarcoma	0.00139	0.00533	CcSEcCtD
Aminocaproic Acid—Myalgia—Vincristine—sarcoma	0.00136	0.00523	CcSEcCtD
Aminocaproic Acid—Convulsion—Mitoxantrone—sarcoma	0.00135	0.00519	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00134	0.00516	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00133	0.00512	CcSEcCtD
Aminocaproic Acid—Myalgia—Mitoxantrone—sarcoma	0.00133	0.0051	CcSEcCtD
Aminocaproic Acid—Discomfort—Mitoxantrone—sarcoma	0.00131	0.00504	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Vincristine—sarcoma	0.00131	0.00502	CcSEcCtD
Aminocaproic Acid—Oedema—Vincristine—sarcoma	0.00131	0.00502	CcSEcCtD
Aminocaproic Acid—Confusional state—Mitoxantrone—sarcoma	0.00128	0.00493	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Vincristine—sarcoma	0.00128	0.00491	CcSEcCtD
Aminocaproic Acid—Oedema—Mitoxantrone—sarcoma	0.00127	0.00489	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Mitoxantrone—sarcoma	0.00127	0.00489	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—PLCG1—sarcoma	0.00126	0.00278	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PLCG1—sarcoma	0.00126	0.00278	CbGpPWpGaD
Aminocaproic Acid—Pain—Thiotepa—sarcoma	0.00126	0.00484	CcSEcCtD
Aminocaproic Acid—Shock—Mitoxantrone—sarcoma	0.00125	0.00481	CcSEcCtD
Aminocaproic Acid—Pain—Dactinomycin—sarcoma	0.00125	0.0048	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Epirubicin—sarcoma	0.00125	0.00479	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Mitoxantrone—sarcoma	0.00124	0.00478	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—KDR—sarcoma	0.00124	0.00275	CbGpPWpGaD
Aminocaproic Acid—Cerebrovascular accident—Epirubicin—sarcoma	0.00123	0.00473	CcSEcCtD
Aminocaproic Acid—Hypotension—Vincristine—sarcoma	0.00122	0.00469	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—MDM2—sarcoma	0.00122	0.00268	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—MDM2—sarcoma	0.00122	0.00268	CbGpPWpGaD
Aminocaproic Acid—Feeling abnormal—Thiotepa—sarcoma	0.00121	0.00466	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Dactinomycin—sarcoma	0.0012	0.00463	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Thiotepa—sarcoma	0.0012	0.00463	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Etoposide—sarcoma	0.0012	0.00462	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Dactinomycin—sarcoma	0.00119	0.00459	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Vincristine—sarcoma	0.00119	0.00457	CcSEcCtD
Aminocaproic Acid—Hypotension—Mitoxantrone—sarcoma	0.00119	0.00457	CcSEcCtD
Aminocaproic Acid—Malaise—Etoposide—sarcoma	0.00117	0.00449	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Thiotepa—sarcoma	0.00116	0.00447	CcSEcCtD
Aminocaproic Acid—Leukopenia—Etoposide—sarcoma	0.00116	0.00446	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00116	0.00445	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Dactinomycin—sarcoma	0.00115	0.00444	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00115	0.00443	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Etoposide—sarcoma	0.00114	0.00438	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Doxorubicin—sarcoma	0.00114	0.00438	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Mitoxantrone—sarcoma	0.00113	0.00436	CcSEcCtD
Aminocaproic Acid—Convulsion—Etoposide—sarcoma	0.00112	0.00432	CcSEcCtD
Aminocaproic Acid—Pain—Vincristine—sarcoma	0.00112	0.00429	CcSEcCtD
Aminocaproic Acid—Discomfort—Etoposide—sarcoma	0.00109	0.00419	CcSEcCtD
Aminocaproic Acid—Pain—Mitoxantrone—sarcoma	0.00109	0.00418	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Thiotepa—sarcoma	0.00108	0.00417	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—TP53—sarcoma	0.00108	0.00239	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Dactinomycin—sarcoma	0.00108	0.00414	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Vincristine—sarcoma	0.00107	0.0041	CcSEcCtD
Aminocaproic Acid—Confusional state—Etoposide—sarcoma	0.00107	0.0041	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Epirubicin—sarcoma	0.00106	0.00409	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Etoposide—sarcoma	0.00106	0.00406	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Mitoxantrone—sarcoma	0.00105	0.00403	CcSEcCtD
Aminocaproic Acid—Pruritus—Thiotepa—sarcoma	0.00104	0.004	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00104	0.004	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—HRAS—sarcoma	0.00104	0.00229	CbGpPWpGaD
Aminocaproic Acid—Thrombocytopenia—Etoposide—sarcoma	0.00104	0.00398	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Vincristine—sarcoma	0.00103	0.00397	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP2—sarcoma	0.00102	0.00224	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Thiotepa—sarcoma	0.00101	0.00387	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Mitoxantrone—sarcoma	0.001	0.00386	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Dactinomycin—sarcoma	0.000999	0.00384	CcSEcCtD
Aminocaproic Acid—Hypotension—Etoposide—sarcoma	0.000988	0.0038	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Doxorubicin—sarcoma	0.000984	0.00378	CcSEcCtD
Aminocaproic Acid—Dizziness—Thiotepa—sarcoma	0.000973	0.00374	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Vincristine—sarcoma	0.000962	0.0037	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—SRC—sarcoma	0.000948	0.00209	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—SRC—sarcoma	0.000948	0.00209	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Etoposide—sarcoma	0.000943	0.00362	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Mitoxantrone—sarcoma	0.000936	0.0036	CcSEcCtD
Aminocaproic Acid—Vomiting—Thiotepa—sarcoma	0.000936	0.0036	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—IL2—sarcoma	0.00093	0.00205	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Dactinomycin—sarcoma	0.000929	0.00357	CcSEcCtD
Aminocaproic Acid—Rash—Thiotepa—sarcoma	0.000928	0.00357	CcSEcCtD
Aminocaproic Acid—Dermatitis—Thiotepa—sarcoma	0.000927	0.00356	CcSEcCtD
Aminocaproic Acid—Headache—Thiotepa—sarcoma	0.000922	0.00355	CcSEcCtD
Aminocaproic Acid—Rash—Dactinomycin—sarcoma	0.000921	0.00354	CcSEcCtD
Aminocaproic Acid—Renal failure—Epirubicin—sarcoma	0.000913	0.00351	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—NRAS—sarcoma	0.000912	0.00201	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—NRAS—sarcoma	0.000912	0.00201	CbGpPWpGaD
Aminocaproic Acid—Pain—Etoposide—sarcoma	0.000904	0.00348	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Vincristine—sarcoma	0.000893	0.00343	CcSEcCtD
Aminocaproic Acid—Nausea—Thiotepa—sarcoma	0.000874	0.00336	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Etoposide—sarcoma	0.000871	0.00335	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Mitoxantrone—sarcoma	0.00087	0.00334	CcSEcCtD
Aminocaproic Acid—Nausea—Dactinomycin—sarcoma	0.000868	0.00334	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Epirubicin—sarcoma	0.000867	0.00333	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Etoposide—sarcoma	0.000864	0.00332	CcSEcCtD
Aminocaproic Acid—Dizziness—Vincristine—sarcoma	0.000863	0.00332	CcSEcCtD
Aminocaproic Acid—Bradycardia—Epirubicin—sarcoma	0.000849	0.00327	CcSEcCtD
Aminocaproic Acid—Renal failure—Doxorubicin—sarcoma	0.000845	0.00325	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Etoposide—sarcoma	0.000836	0.00321	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—EGFR—sarcoma	0.000831	0.00183	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—EGFR—sarcoma	0.000831	0.00183	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Vincristine—sarcoma	0.00083	0.00319	CcSEcCtD
Aminocaproic Acid—Rash—Vincristine—sarcoma	0.000823	0.00316	CcSEcCtD
Aminocaproic Acid—Dermatitis—Vincristine—sarcoma	0.000822	0.00316	CcSEcCtD
Aminocaproic Acid—Headache—Vincristine—sarcoma	0.000818	0.00314	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000811	0.00179	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Mitoxantrone—sarcoma	0.000808	0.00311	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Doxorubicin—sarcoma	0.000802	0.00308	CcSEcCtD
Aminocaproic Acid—Rash—Mitoxantrone—sarcoma	0.000801	0.00308	CcSEcCtD
Aminocaproic Acid—Dermatitis—Mitoxantrone—sarcoma	0.000801	0.00308	CcSEcCtD
Aminocaproic Acid—Headache—Mitoxantrone—sarcoma	0.000796	0.00306	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.00079	0.00174	CbGpPWpGaD
Aminocaproic Acid—Bradycardia—Doxorubicin—sarcoma	0.000786	0.00302	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—KRAS—sarcoma	0.000785	0.00173	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—KRAS—sarcoma	0.000785	0.00173	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Etoposide—sarcoma	0.000779	0.00299	CcSEcCtD
Aminocaproic Acid—Tinnitus—Epirubicin—sarcoma	0.000778	0.00299	CcSEcCtD
Aminocaproic Acid—Nausea—Vincristine—sarcoma	0.000775	0.00298	CcSEcCtD
Aminocaproic Acid—Nausea—Mitoxantrone—sarcoma	0.000755	0.0029	CcSEcCtD
Aminocaproic Acid—Pruritus—Etoposide—sarcoma	0.000748	0.00288	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Etoposide—sarcoma	0.000723	0.00278	CcSEcCtD
Aminocaproic Acid—Tinnitus—Doxorubicin—sarcoma	0.00072	0.00277	CcSEcCtD
Aminocaproic Acid—Dizziness—Etoposide—sarcoma	0.000699	0.00269	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Epirubicin—sarcoma	0.000674	0.00259	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—TLE1—sarcoma	0.000673	0.00148	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Etoposide—sarcoma	0.000672	0.00258	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—HRAS—sarcoma	0.000667	0.00147	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—HRAS—sarcoma	0.000667	0.00147	CbGpPWpGaD
Aminocaproic Acid—Rash—Etoposide—sarcoma	0.000667	0.00256	CcSEcCtD
Aminocaproic Acid—Dermatitis—Etoposide—sarcoma	0.000666	0.00256	CcSEcCtD
Aminocaproic Acid—Headache—Etoposide—sarcoma	0.000662	0.00255	CcSEcCtD
Aminocaproic Acid—Malaise—Epirubicin—sarcoma	0.000655	0.00252	CcSEcCtD
Aminocaproic Acid—Syncope—Epirubicin—sarcoma	0.000651	0.0025	CcSEcCtD
Aminocaproic Acid—Leukopenia—Epirubicin—sarcoma	0.00065	0.0025	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—TLE1—sarcoma	0.000644	0.00142	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TLE1—sarcoma	0.000644	0.00142	CbGpPWpGaD
Aminocaproic Acid—Loss of consciousness—Epirubicin—sarcoma	0.000638	0.00245	CcSEcCtD
Aminocaproic Acid—Convulsion—Epirubicin—sarcoma	0.000629	0.00242	CcSEcCtD
Aminocaproic Acid—Nausea—Etoposide—sarcoma	0.000628	0.00241	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Doxorubicin—sarcoma	0.000623	0.0024	CcSEcCtD
Aminocaproic Acid—Myalgia—Epirubicin—sarcoma	0.000618	0.00238	CcSEcCtD
Aminocaproic Acid—Discomfort—Epirubicin—sarcoma	0.000611	0.00235	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—NPM1—sarcoma	0.000607	0.00134	CbGpPWpGaD
Aminocaproic Acid—Malaise—Doxorubicin—sarcoma	0.000606	0.00233	CcSEcCtD
Aminocaproic Acid—Syncope—Doxorubicin—sarcoma	0.000603	0.00232	CcSEcCtD
Aminocaproic Acid—Leukopenia—Doxorubicin—sarcoma	0.000601	0.00231	CcSEcCtD
Aminocaproic Acid—Confusional state—Epirubicin—sarcoma	0.000598	0.0023	CcSEcCtD
Aminocaproic Acid—Oedema—Epirubicin—sarcoma	0.000593	0.00228	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Epirubicin—sarcoma	0.000593	0.00228	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Doxorubicin—sarcoma	0.000591	0.00227	CcSEcCtD
Aminocaproic Acid—Shock—Epirubicin—sarcoma	0.000583	0.00224	CcSEcCtD
Aminocaproic Acid—Convulsion—Doxorubicin—sarcoma	0.000582	0.00224	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Epirubicin—sarcoma	0.00058	0.00223	CcSEcCtD
Aminocaproic Acid—Myalgia—Doxorubicin—sarcoma	0.000572	0.0022	CcSEcCtD
Aminocaproic Acid—Discomfort—Doxorubicin—sarcoma	0.000565	0.00217	CcSEcCtD
Aminocaproic Acid—Hypotension—Epirubicin—sarcoma	0.000554	0.00213	CcSEcCtD
Aminocaproic Acid—Confusional state—Doxorubicin—sarcoma	0.000553	0.00213	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Doxorubicin—sarcoma	0.000548	0.00211	CcSEcCtD
Aminocaproic Acid—Oedema—Doxorubicin—sarcoma	0.000548	0.00211	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—VEGFC—sarcoma	0.000543	0.0012	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—VEGFC—sarcoma	0.000543	0.0012	CbGpPWpGaD
Aminocaproic Acid—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00054	0.00208	CcSEcCtD
Aminocaproic Acid—Shock—Doxorubicin—sarcoma	0.000539	0.00207	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Doxorubicin—sarcoma	0.000537	0.00206	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Epirubicin—sarcoma	0.000528	0.00203	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—ENO2—sarcoma	0.000525	0.00116	CbGpPWpGaD
Aminocaproic Acid—Hypotension—Doxorubicin—sarcoma	0.000512	0.00197	CcSEcCtD
Aminocaproic Acid—Pain—Epirubicin—sarcoma	0.000507	0.00195	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.0005	0.00192	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Doxorubicin—sarcoma	0.000489	0.00188	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Epirubicin—sarcoma	0.000488	0.00188	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Epirubicin—sarcoma	0.000485	0.00186	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—IL2—sarcoma	0.000479	0.00106	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—IL2—sarcoma	0.000479	0.00106	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—MMP2—sarcoma	0.000475	0.00105	CbGpPWpGaD
Aminocaproic Acid—Pain—Doxorubicin—sarcoma	0.000469	0.0018	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Epirubicin—sarcoma	0.000468	0.0018	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Doxorubicin—sarcoma	0.000452	0.00174	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Doxorubicin—sarcoma	0.000448	0.00172	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—PLCG1—sarcoma	0.000446	0.000984	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ENO2—sarcoma	0.00044	0.000971	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HBA1—sarcoma	0.000437	0.000965	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Epirubicin—sarcoma	0.000437	0.00168	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—FLT1—sarcoma	0.000434	0.000959	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—FLT1—sarcoma	0.000434	0.000959	CbGpPWpGaD
Aminocaproic Acid—Abdominal pain—Doxorubicin—sarcoma	0.000433	0.00167	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—CXCR4—sarcoma	0.000428	0.000946	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PLCG1—sarcoma	0.000427	0.000943	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PLCG1—sarcoma	0.000427	0.000943	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Epirubicin—sarcoma	0.000419	0.00161	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—SRC—sarcoma	0.000418	0.000923	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—SRC—sarcoma	0.000418	0.000923	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CXCR4—sarcoma	0.00041	0.000906	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CXCR4—sarcoma	0.00041	0.000906	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—VEGFA—sarcoma	0.000407	0.000899	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—VEGFA—sarcoma	0.000407	0.000899	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ATF1—sarcoma	0.000406	0.000895	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ATF1—sarcoma	0.000406	0.000895	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Epirubicin—sarcoma	0.000405	0.00156	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Doxorubicin—sarcoma	0.000404	0.00155	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—NRAS—sarcoma	0.000402	0.000888	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—NRAS—sarcoma	0.000402	0.000888	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Epirubicin—sarcoma	0.000392	0.00151	CcSEcCtD
Aminocaproic Acid—Pruritus—Doxorubicin—sarcoma	0.000388	0.00149	CcSEcCtD
Aminocaproic Acid—Vomiting—Epirubicin—sarcoma	0.000377	0.00145	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Doxorubicin—sarcoma	0.000375	0.00144	CcSEcCtD
Aminocaproic Acid—Rash—Epirubicin—sarcoma	0.000374	0.00144	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—PLCG1—sarcoma	0.000373	0.000824	CbGpPWpGaD
Aminocaproic Acid—Dermatitis—Epirubicin—sarcoma	0.000373	0.00144	CcSEcCtD
Aminocaproic Acid—Headache—Epirubicin—sarcoma	0.000371	0.00143	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—CTNNB1—sarcoma	0.000364	0.000803	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Doxorubicin—sarcoma	0.000363	0.00139	CcSEcCtD
Aminocaproic Acid—Nausea—Epirubicin—sarcoma	0.000352	0.00135	CcSEcCtD
Aminocaproic Acid—Vomiting—Doxorubicin—sarcoma	0.000349	0.00134	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—KRAS—sarcoma	0.000346	0.000764	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—KRAS—sarcoma	0.000346	0.000764	CbGpPWpGaD
Aminocaproic Acid—Rash—Doxorubicin—sarcoma	0.000346	0.00133	CcSEcCtD
Aminocaproic Acid—Dermatitis—Doxorubicin—sarcoma	0.000345	0.00133	CcSEcCtD
Aminocaproic Acid—Headache—Doxorubicin—sarcoma	0.000344	0.00132	CcSEcCtD
Aminocaproic Acid—Nausea—Doxorubicin—sarcoma	0.000326	0.00125	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—IGF1R—sarcoma	0.000318	0.000703	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IGF1R—sarcoma	0.000318	0.000703	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—FOXO1—sarcoma	0.000316	0.000698	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PDGFRB—sarcoma	0.000316	0.000697	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PDGFRA—sarcoma	0.000311	0.000686	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—TP53—sarcoma	0.000308	0.000679	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—TP53—sarcoma	0.000308	0.000679	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—FOXO1—sarcoma	0.000303	0.000669	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—FOXO1—sarcoma	0.000303	0.000669	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PDGFRB—sarcoma	0.000302	0.000668	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PDGFRB—sarcoma	0.000302	0.000668	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PDGFRA—sarcoma	0.000298	0.000657	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PDGFRA—sarcoma	0.000298	0.000657	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—HRAS—sarcoma	0.000294	0.00065	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—HRAS—sarcoma	0.000294	0.00065	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KDR—sarcoma	0.000251	0.000553	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KDR—sarcoma	0.000251	0.000553	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—KIT—sarcoma	0.000241	0.000532	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KIT—sarcoma	0.000231	0.00051	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KIT—sarcoma	0.000231	0.00051	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CREB1—sarcoma	0.000229	0.000507	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CREB1—sarcoma	0.00022	0.000485	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CREB1—sarcoma	0.00022	0.000485	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MDM2—sarcoma	0.00019	0.000419	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MDM2—sarcoma	0.000182	0.000401	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MDM2—sarcoma	0.000182	0.000401	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CTNNB1—sarcoma	0.000164	0.000361	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IL2—sarcoma	0.000162	0.000359	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL2—sarcoma	0.000162	0.000359	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CCND1—sarcoma	0.000158	0.00035	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CCND1—sarcoma	0.000158	0.00035	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—JUN—sarcoma	0.000158	0.000349	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—JUN—sarcoma	0.000158	0.000349	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CTNNB1—sarcoma	0.000157	0.000346	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CTNNB1—sarcoma	0.000157	0.000346	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SRC—sarcoma	0.000148	0.000327	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NRAS—sarcoma	0.000142	0.000314	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SRC—sarcoma	0.000142	0.000313	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—SRC—sarcoma	0.000142	0.000313	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—VEGFA—sarcoma	0.000138	0.000305	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—VEGFA—sarcoma	0.000138	0.000305	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—NRAS—sarcoma	0.000136	0.000301	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—NRAS—sarcoma	0.000136	0.000301	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MYC—sarcoma	0.000133	0.000293	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EGFR—sarcoma	0.00013	0.000286	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MYC—sarcoma	0.000127	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MYC—sarcoma	0.000127	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EGFR—sarcoma	0.000124	0.000274	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EGFR—sarcoma	0.000124	0.000274	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—KRAS—sarcoma	0.000123	0.000271	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KRAS—sarcoma	0.000117	0.000259	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KRAS—sarcoma	0.000117	0.000259	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TP53—sarcoma	0.000104	0.00023	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TP53—sarcoma	0.000104	0.00023	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—HRAS—sarcoma	0.000104	0.00023	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HRAS—sarcoma	9.98e-05	0.00022	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—HRAS—sarcoma	9.98e-05	0.00022	CbGpPWpGaD
